Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us
Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eyes optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people. Glaucoma is generally categorized as open-angle glaucoma (OAG), angle-closure glaucoma (ACG), secondary glaucoma, and congenital glaucoma.
To Browse a Full Report with Toc: http://www.researchmoz.us/epicast-report-glaucoma-epidemiology-forecast-to-2023-report.html
Other less common types of glaucoma include normal-tension glaucoma (NTG), pseudoexfoliation glaucoma, and pigmentary glaucoma (NEI, 2014b). Although there are many types of glaucoma, the two most important types are OAG and ACG, with OAG accounting for about 80-90% of all glaucoma cases (Mayo Clinic, 2014). OAG and ACG can be primary (primary open-angle glaucoma [POAG] and primary angle-closure glaucoma [PACG], respectively) or secondary, depending on the cause.
GlobalData epidemiologists forecast that the total prevalent cases of glaucoma in the 7MM will grow by 14.60% over the next decade, from 13,748,430 total prevalent cases in 2013 to 15,761,674 total prevalent cases in 2023, with almost 60% of the total prevalent cases occurring in the US and Japan together.
The increase in the number of total prevalent cases of glaucoma in the 7MM can be attributed to changing population demographics in the respective markets. However, further epidemiological research is warranted given that there is a paucity of national and international data evaluating the prevalence and trends of glaucoma worldwide. There is also a need to clearly demarcate the glaucoma population in each clinical type, as currently available epidemiological literature fails to clearly demarcate different glaucoma populations.
Scope
The Glaucoma EpiCast Report provides an overview of the risk factors and global trends of glaucoma in the 7MM (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiology forecast of total prevalent cases of glaucoma segmented by age (in five-year increments beginning at age 40), sex, clinical type (POAG, PACG, secondary glaucoma, and congenital glaucoma the total prevalent cases of NTG, which is a sub-type of OAG; and the diagnosed prevalent cases of POAG and PACG in these markets.
The glaucoma epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
Develop business strategies by understanding the trends shaping and driving the global glaucoma market.
Quantify patient populations in the global glaucoma market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for glaucoma therapeutics in each of the markets covered.
Identify the percentage of glaucoma prevalent cases by clinical type.
Table Of Content
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 11
3.3 Global Trends 13
3.3.1 US 13
3.3.2 5EU 14
3.3.3 Japan 15
4 Appendix 45
4.1 Bibliography 45
4.2 About the Authors 48
4.2.1 Epidemiologists 48
4.2.2 Reviewers 48
4.2.3 Global Director of Therapy Analysis and Epidemiology 49
4.2.4 Global Head of Healthcare 50
4.3 About GlobalData 51
4.4 About EpiCast 51
4.5 Disclaimer 51
List of Tables
Table 1: Types of Glaucoma 10
Table 2: Risk Factors and Comorbidities for Glaucoma 12
Table 3: 7MM, Sources of Glaucoma Total Prevalence Data Used in the Epidemiology Forecast 17
Table 4: 7MM, Sources of Epidemiological Data Used to Forecast the Total Prevalent Cases of Glaucoma Segmented by Clinical Types 18
Table 5: 7MM, Sources Not Used in the Epidemiological Analysis of Glaucoma 28
Table 6: 7MM, Total Prevalent Cases of Glaucoma, Ages ≥40 Years, Both Sexes, N, 2013-2023 29
Table 7: 7MM, Total Prevalent Cases of Glaucoma, by Age, Both Sexes, N (Row %), 2013 31
Table 8: 7MM, Total Prevalent Cases of Glaucoma, by Sex, Ages ≥40 Years, N (Row %), 2013 33
Table 9: 7MM, Total Prevalent Cases of Glaucoma, by Clinical Type, Ages ≥40 Years, N (Row %), 2013 36
Table 10: 7MM, Total Prevalent Cases of NTG, Ages ≥40 Years, Both Sexes, N, 2013-2023 38
Table 11: 7MM, Diagnosed Prevalent Cases of POAG, Ages ≥40 Years, Both Sexes, N, 2013-2023 39
Table 12: 7MM, Diagnosed Prevalent Cases of PACG, Ages ≥40 Years, Both Sexes, N, 2013-2023 41
To Get Sample Report With Toc: http://www.researchmoz.us/enquiry.php?type=sample&repid=287108
All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact US:
For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/412072972
Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eyes optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people. Glaucoma is generally categorized as open-angle glaucoma (OAG), angle-closure glaucoma (ACG), secondary glaucoma, and congenital glaucoma.
To Browse a Full Report with Toc: http://www.researchmoz.us/epicast-report-glaucoma-epidemiology-forecast-to-2023-report.html
Other less common types of glaucoma include normal-tension glaucoma (NTG), pseudoexfoliation glaucoma, and pigmentary glaucoma (NEI, 2014b). Although there are many types of glaucoma, the two most important types are OAG and ACG, with OAG accounting for about 80-90% of all glaucoma cases (Mayo Clinic, 2014). OAG and ACG can be primary (primary open-angle glaucoma [POAG] and primary angle-closure glaucoma [PACG], respectively) or secondary, depending on the cause.
GlobalData epidemiologists forecast that the total prevalent cases of glaucoma in the 7MM will grow by 14.60% over the next decade, from 13,748,430 total prevalent cases in 2013 to 15,761,674 total prevalent cases in 2023, with almost 60% of the total prevalent cases occurring in the US and Japan together.
The increase in the number of total prevalent cases of glaucoma in the 7MM can be attributed to changing population demographics in the respective markets. However, further epidemiological research is warranted given that there is a paucity of national and international data evaluating the prevalence and trends of glaucoma worldwide. There is also a need to clearly demarcate the glaucoma population in each clinical type, as currently available epidemiological literature fails to clearly demarcate different glaucoma populations.
Scope
The Glaucoma EpiCast Report provides an overview of the risk factors and global trends of glaucoma in the 7MM (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiology forecast of total prevalent cases of glaucoma segmented by age (in five-year increments beginning at age 40), sex, clinical type (POAG, PACG, secondary glaucoma, and congenital glaucoma the total prevalent cases of NTG, which is a sub-type of OAG; and the diagnosed prevalent cases of POAG and PACG in these markets.
The glaucoma epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
Develop business strategies by understanding the trends shaping and driving the global glaucoma market.
Quantify patient populations in the global glaucoma market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for glaucoma therapeutics in each of the markets covered.
Identify the percentage of glaucoma prevalent cases by clinical type.
Table Of Content
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 11
3.3 Global Trends 13
3.3.1 US 13
3.3.2 5EU 14
3.3.3 Japan 15
4 Appendix 45
4.1 Bibliography 45
4.2 About the Authors 48
4.2.1 Epidemiologists 48
4.2.2 Reviewers 48
4.2.3 Global Director of Therapy Analysis and Epidemiology 49
4.2.4 Global Head of Healthcare 50
4.3 About GlobalData 51
4.4 About EpiCast 51
4.5 Disclaimer 51
List of Tables
Table 1: Types of Glaucoma 10
Table 2: Risk Factors and Comorbidities for Glaucoma 12
Table 3: 7MM, Sources of Glaucoma Total Prevalence Data Used in the Epidemiology Forecast 17
Table 4: 7MM, Sources of Epidemiological Data Used to Forecast the Total Prevalent Cases of Glaucoma Segmented by Clinical Types 18
Table 5: 7MM, Sources Not Used in the Epidemiological Analysis of Glaucoma 28
Table 6: 7MM, Total Prevalent Cases of Glaucoma, Ages ≥40 Years, Both Sexes, N, 2013-2023 29
Table 7: 7MM, Total Prevalent Cases of Glaucoma, by Age, Both Sexes, N (Row %), 2013 31
Table 8: 7MM, Total Prevalent Cases of Glaucoma, by Sex, Ages ≥40 Years, N (Row %), 2013 33
Table 9: 7MM, Total Prevalent Cases of Glaucoma, by Clinical Type, Ages ≥40 Years, N (Row %), 2013 36
Table 10: 7MM, Total Prevalent Cases of NTG, Ages ≥40 Years, Both Sexes, N, 2013-2023 38
Table 11: 7MM, Diagnosed Prevalent Cases of POAG, Ages ≥40 Years, Both Sexes, N, 2013-2023 39
Table 12: 7MM, Diagnosed Prevalent Cases of PACG, Ages ≥40 Years, Both Sexes, N, 2013-2023 41
To Get Sample Report With Toc: http://www.researchmoz.us/enquiry.php?type=sample&repid=287108
All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact US:
For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/412072972
No comments:
Post a Comment